IL10 and neoplasm: In TME, M2 TAMs secrete immunosuppressive factors such as IL-10 and vascular endothelial growth factor (VEGF), along with matrix metalloproteinases, which facilitate tumor progression and metastatic spread while simultaneously inhibiting the activation and proliferation of effector T-cells [43].